AU5509099A - Pyridinones for the treatment of sexual dysfunction - Google Patents

Pyridinones for the treatment of sexual dysfunction

Info

Publication number
AU5509099A
AU5509099A AU55090/99A AU5509099A AU5509099A AU 5509099 A AU5509099 A AU 5509099A AU 55090/99 A AU55090/99 A AU 55090/99A AU 5509099 A AU5509099 A AU 5509099A AU 5509099 A AU5509099 A AU 5509099A
Authority
AU
Australia
Prior art keywords
pyridinones
treatment
sexual dysfunction
sexual
dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55090/99A
Inventor
Neil R. Manowitz
Hugh E. Morgan
Robert A. O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Corp
Original Assignee
BASF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Corp filed Critical BASF Corp
Publication of AU5509099A publication Critical patent/AU5509099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
AU55090/99A 1998-08-03 1999-07-31 Pyridinones for the treatment of sexual dysfunction Abandoned AU5509099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9506098P 1998-08-03 1998-08-03
US60095060 1998-08-03
PCT/EP1999/005544 WO2000007595A1 (en) 1998-08-03 1999-07-31 Pyridinones for the treatment of sexual dysfunction

Publications (1)

Publication Number Publication Date
AU5509099A true AU5509099A (en) 2000-02-28

Family

ID=22249125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55090/99A Abandoned AU5509099A (en) 1998-08-03 1999-07-31 Pyridinones for the treatment of sexual dysfunction

Country Status (5)

Country Link
EP (1) EP1107759A1 (en)
JP (1) JP2002522388A (en)
AU (1) AU5509099A (en)
CA (1) CA2339484A1 (en)
WO (1) WO2000007595A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541487B1 (en) * 1998-05-01 2003-04-01 R.T. Alamo Ventures I, Llc PDE III inhibitors for treating sexual dysfunction
CA2319542C (en) * 1998-05-01 2005-07-12 Rt Alamo Ventures, Inc. The treatment of sexual dysfunction in certain patient groups
CA2435876A1 (en) * 2001-01-26 2002-08-01 R.T. Alamo Ventures I, Llc The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
AR038117A1 (en) 2002-01-14 2004-12-29 Upjohn Co ANTIVIRAL AGENTS DERIVED FROM 4- OXO-4,7 -DIHYDROFIDE [2,3-B] PIRIDIN-5-CARBOXAMIDA
AR038294A1 (en) 2002-01-14 2005-01-12 Upjohn Co OXOTIENE (3,2-B) PYRIDINCARBOXAMIDS AS ANTIVIRAL AGENTS
AR038118A1 (en) 2002-01-14 2004-12-29 Upjohn Co COMPOUNDS DERIVED FROM ACID BENCINAMIDE 7-OXO-4,7-DIHIDROTIEN [2,3-B [PIRIDIN-6-CARBOXYLIC 3-REPLACED WHICH ARE USEFUL AS ANTIVIRAL
GB201516504D0 (en) 2015-09-17 2015-11-04 Astrazeneca Ab Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer
JOP20190086A1 (en) 2016-10-21 2019-04-18 Novartis Ag Naphthyridinone derivatives and their use in the treatment of arrhythmia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
DE3576686D1 (en) * 1984-08-15 1990-04-26 Boots Co Ltd CHINOLINONES, PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
AU2345192A (en) * 1992-07-21 1994-02-14 Boots Company Plc, The Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris

Also Published As

Publication number Publication date
JP2002522388A (en) 2002-07-23
CA2339484A1 (en) 2000-02-17
WO2000007595A1 (en) 2000-02-17
EP1107759A1 (en) 2001-06-20

Similar Documents

Publication Publication Date Title
ZA99686B (en) Treatment of female sexual dysfunction.
IL141553A0 (en) Drug preparations for treating sexual dysfunction
GB9824436D0 (en) Methods of treatment
AU3784999A (en) Methods for treatment of pain
AU3894600A (en) Method of treating sexual dysfunction
AU5038299A (en) Process for the biocidal treatment of surfaces
HUP0200738A3 (en) Method of the treatment of incontinence
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
AU1697197A (en) Immunoconjugate for the treatment of aids
AU3776799A (en) Methods for treating female sexual dysfunction
AU7750100A (en) Method for the treatment of obesity
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
IL155769A0 (en) Method for the treatment of inflammation
AU9583498A (en) Method for treating sexual dysfunction
GB2332849B (en) Apparatus for the treatment of soil
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU4598400A (en) Method of treatment
ZA200007396B (en) Method of treatment.
SI1047428T1 (en) Use of morpholinol for the treatment of sexual dysfunction
AU6112299A (en) Treatment of effluents
AU4385499A (en) Pharmaceutical composition for treating sexual dysfunction
AU8779298A (en) Limb massager
AU2003208111A1 (en) Method and composition for the treatment or amelioration of female sexual dysfunction
AUPP584798A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase